Targeted next generation sequencing of candidate genes in patients with PD and healthy controls has supported roles for specific genetic variants in the pathogenesis of the disease, such as variants in GCH1, MAPT [23], and SMPD1 [43], and demonstrated lack of association with other genes [44–46]. The gene discussed is SMPD1; the disease is Parkinson disease.